Biogen stock gains on leaked Alzheimer's drug data

Biogen is scheduled to present early-stage data on aducanumab at a medical industry conference in San Diego on Friday, but an embargoed abstract of the presentation was leaked Thursday afternoon.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.